Scribe publisher Henry Rosenbloom has acquired UK and Commonwealth rights to two works of US nonfiction exploring bias across gender and racial lines.
Women’s Work: A Reckoning with Home and Help by foreign correspondent Megan Stack blends memoir and reportage to offer a profound look into the forgotten cornerstone of the world — the household. She writes ‘We avoid the subject of domestic labour as if it were something deeply private, like a sexual proclivity, rather than a ubiquitous physical demand that has hamstrung and silenced women for most of human history. We like to think the struggle for women’s equality exists in offices and manufacturing plants, but I am convinced this battle takes place, first and most crushingly, at home.’
Women’s Work is both Stack’s fearless account of being a working mother herself, and an investigation into the terrible challenges domestic employees experience around the world.
Rights were acquired from Kathy Robbins at The Robbins Office. Doubleday will publish in the US in Spring 2019. Scribe will publish in Australia in April 2019 and in the UK in July 2019.
Rosenbloom has also acquired rights to Under the Skin, a ground-breaking book about race and health by Linda Villarosa, currently a contributing writer at The New York Times Magazine. Under the Skin is a rigorous examination of race and health that exposes a shocking truth: it reveals the ways that an insidious, deeply rooted racial and ethnic bias in the healthcare system affects who lives and who dies. It diagnoses both the problems of widespread, systemic inequality and the often surprising root causes for these disparities — and most movingly, shows the costs of this racism at the individual level. Bringing together meticulous research and richly drawn, character-driven narratives, it illustrates why being black is so detrimental to well-being.
Rights were acquired from Amberley Lewis at Abner Stein on behalf of The Gernert Company. Under The Skin will be published in the US by Doubleday. It will be released in the US, UK, and ANZ in late 2020.